One of the markers intensively studied in the setting of RCC is Hb levels, research showing that lower levels of Hb correlate with shorter survival in patients diagnosed with RCC in the setting of both metastatic and non- metastatic patients (46–48). The gene discussed is GSTM1; the disease is renal cell carcinoma.